Weibo Xu

1.7k total citations
52 papers, 1.2k citations indexed

About

Weibo Xu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weibo Xu has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weibo Xu's work include Thyroid Cancer Diagnosis and Treatment (11 papers), RNA modifications and cancer (10 papers) and Ferroptosis and cancer prognosis (9 papers). Weibo Xu is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (11 papers), RNA modifications and cancer (10 papers) and Ferroptosis and cancer prognosis (9 papers). Weibo Xu collaborates with scholars based in China, United States and Russia. Weibo Xu's co-authors include Junkai Chang, Xinyi Du, Junqing Hou, Glen K. Andrews, Delinda A. Johnson, Jeffrey Johnson, Jianli Hua, Zhicheng Yang, Ben Ma and Tian Liao and has published in prestigious journals such as Analytical Chemistry, The Journal of Clinical Endocrinology & Metabolism and ACS Applied Materials & Interfaces.

In The Last Decade

Weibo Xu

51 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weibo Xu China	20	576	322	181	159	151	52	1.2k
Qingchun Mu China	19	551 1.0×	211 0.7×	77 0.4×	126 0.8×	48 0.3×	48	1.1k
Chenyi Jiang China	20	406 0.7×	288 0.9×	178 1.0×	71 0.4×	48 0.3×	43	1.1k
Hengyu Chen China	19	646 1.1×	453 1.4×	133 0.7×	114 0.7×	33 0.2×	46	1.1k
Jihye Yun United States	12	1.3k 2.2×	669 2.1×	201 1.1×	144 0.9×	37 0.2×	23	2.3k
Chengde Wang China	17	509 0.9×	160 0.5×	89 0.5×	78 0.5×	60 0.4×	64	1.1k
Silvia Rocchiccioli Italy	19	439 0.8×	112 0.3×	100 0.6×	41 0.3×	76 0.5×	106	1.2k
Wenbo Zhi United States	19	503 0.9×	116 0.4×	50 0.3×	56 0.4×	95 0.6×	67	1.1k
Peng Shen China	24	1.3k 2.3×	773 2.4×	211 1.2×	79 0.5×	90 0.6×	71	2.1k
Shuangping Liu China	23	969 1.7×	388 1.2×	101 0.6×	84 0.5×	18 0.1×	62	1.7k

Countries citing papers authored by Weibo Xu

Since Specialization

Citations

This map shows the geographic impact of Weibo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Xu more than expected).

Fields of papers citing papers by Weibo Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weibo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Xu. The network helps show where Weibo Xu may publish in the future.

Co-authorship network of co-authors of Weibo Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Weibo Xu. A scholar is included among the top collaborators of Weibo Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weibo Xu. Weibo Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liao, Tian, Yu Zeng, Weibo Xu, et al.. (2025). A spatially resolved transcriptome landscape during thyroid cancer progression. Cell Reports Medicine. 6(4). 102043–102043. 5 indexed citations

Xu, Weibo, Fan Cao, Peng Liu, Kang Yan, & Qian‐Huan Guo. (2024). The multifaceted role of RNA-based regulation in plant stress memory. Frontiers in Plant Science. 15. 1387575–1387575. 8 indexed citations

Sang, Youzhou, Weibo Xu, Wanlin Liu, et al.. (2024). Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer. Advanced Science. 12(7). e2413514–e2413514. 3 indexed citations

Qi, Yanyu, et al.. (2024). Long-term efficacy of lobectomy for stage T1 papillary thyroid carcinoma with varying degrees of lymph node metastasis. Frontiers in Endocrinology. 15. 1453601–1453601.

Xu, Weibo, et al.. (2024). Adaptive soft threshold transformer for radar high‐resolution range profile target recognition. IET Radar Sonar & Navigation. 18(8). 1260–1273. 4 indexed citations

Xu, Weibo, Qian‐Huan Guo, Peng Liu, et al.. (2024). A long non-coding RNA functions as a competitive endogenous RNA to modulate TaNAC018 by acting as a decoy for tae-miR6206. Plant Molecular Biology. 114(3). 36–36. 6 indexed citations

Ma, Ben, Yi Luo, Weibo Xu, et al.. (2023). LINC00886 Negatively Regulates Malignancy in Anaplastic Thyroid Cancer. Endocrinology. 164(4). 6 indexed citations

Yang, Yichen, Ben Ma, Weibo Xu, et al.. (2022). Integrated single-cell and bulk RNA sequencing analyses reveal a prognostic signature of cancer-associated fibroblasts in head and neck squamous cell carcinoma. Frontiers in Genetics. 13. 1028469–1028469. 8 indexed citations

Xu, Weibo, Cuiwei Li, Ben Ma, et al.. (2021). Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer. Frontiers in Oncology. 11. 641851–641851. 5 indexed citations

10.

Ma, Ben, Hongyi Jiang, Yi Luo, et al.. (2021). Tumor-Infiltrating Immune-Related Long Non-Coding RNAs Indicate Prognoses and Response to PD-1 Blockade in Head and Neck Squamous Cell Carcinoma. Frontiers in Immunology. 12. 692079–692079. 5 indexed citations

11.

Zhao, Xiaolei, Zhenhua Zhao, Wenchao Xu, et al.. (2020). <p>Circ-SAR1A Promotes Renal Cell Carcinoma Progression Through miR-382/YBX1 Axis</p>. Cancer Management and Research. Volume 12. 7353–7361. 17 indexed citations

12.

Jiang, Hongyi, Ben Ma, Weibo Xu, et al.. (2020). A Novel Three-lncRNA Signature Predicts the Overall Survival of HNSCC Patients. Annals of Surgical Oncology. 28(6). 3396–3406. 14 indexed citations

13.

Ma, Ben, Hongyi Jiang, Duo Wen, et al.. (2019). Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 104(9). 3713–3725. 32 indexed citations

14.

Shi, Xiao, Pengcheng Yu, Yan Zhang, et al.. (2019). Association Between Programmed Death-Ligand 1 Expression and Clinicopathological Characteristics, Structural Recurrence, and Biochemical Recurrence/Persistent Disease in Medullary Thyroid Carcinoma. Thyroid. 29(9). 1269–1278. 34 indexed citations

15.

Xu, Weibo, Yanqing Qu, Wen Shi, et al.. (2019). Multiple bone brown tumor secondary to primary hyperparathyroidism: a case report and literature review. Gland Surgery. 8(6). 810–816. 13 indexed citations

16.

Ma, Ben, Weibo Xu, Wenjun Wei, et al.. (2018). Clinicopathological and Survival Outcomes of Well-Differentiated Thyroid Carcinoma Undergoing Dedifferentiation: A Retrospective Study from FUSCC. International Journal of Endocrinology. 2018. 1–11. 17 indexed citations

17.

Chang, Junkai, Weibo Xu, Xinyi Du, & Junqing Hou. (2018). MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS. OncoTargets and Therapy. Volume 11. 3461–3473. 61 indexed citations

18.

Wang, Jian, Weibo Xu, Zhicheng Yang, et al.. (2018). New Diketopyrrolopyrrole-Based Ratiometric Fluorescent Probe for Intracellular Esterase Detection and Discrimination of Live and Dead Cells in Different Fluorescence Channels. ACS Applied Materials & Interfaces. 10(37). 31088–31095. 63 indexed citations

19.

Hou, Junqing, Zhenhua Zhao, Tie‐Qiang Li, et al.. (2017). Expression of speckle-type poxvirus and zinc finger protein in prostate cancer. Zhonghua shiyan waike zazhi. 34(3). 509–511. 1 indexed citations

20.

Xu, Weibo, Junkai Chang, Guangchao Liu, Xinyi Du, & Xiaodong Li. (2017). Knockdown of FOXR2 suppresses the tumorigenesis, growth and metastasis of prostate cancer. Biomedicine & Pharmacotherapy. 87. 471–475. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact